Praxis Precision Medicines (PRAX) Insider & Congress Trades

Smart money at a glance

Filings to Oct 31, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: net buying of $2K to $30K in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: +$2K to +$30K netNet buying
Big fundsSEC 13F, quarter ended Jun 30, 2026: 1 added, 0 cutMore adding

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about PRAX filings

Are insiders buying or selling Praxis Precision Medicines Inc (PRAX) stock?

Neither. Praxis Precision Medicines Inc (PRAX) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded PRAX recently?

Rep. Gilbert Cisneros (D) bought $1K to $15K on Sep 29, 2026, disclosed 13 days later. Rep. Gilbert Cisneros (D) bought $1K to $15K on Jul 30, 2026, disclosed 36 days later. In total, 1 member disclosed 2 PRAX trades with trade dates in the last 180 days, filed a median 25 days after trading.

How current is this PRAX smart-money data?

This summary uses filings available on Oct 31, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on PRAX

Lean long2 sources:
- Politicians
- Funds
Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
- Jill DeSimone, sold $3.6M, scheduled plan sale, filed Jun 26
Lean short · thin1 sale · $3.6M
1 of 1 on scheduled plans. Form 4 filings.
Politicians
- Gilbert Cisneros, bought $1K–$15K, disclosed Oct 12
- Gilbert Cisneros, bought $1K–$15K, disclosed Sep 4
Lean long · thin2 buys · 0 salesCongress
Congress filings. Amounts are filing ranges, not prices, and filings can lag the trade.
Funds
Lean long2 added · 1 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about PRAX filings

Are insiders buying or selling Praxis Precision Medicines Inc (PRAX) stock?

Neither. Praxis Precision Medicines Inc (PRAX) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded PRAX recently?

How current is this PRAX smart-money data?

Funds

What funds are doing

4 moves · 6 mo

Buys/Adds$337.5MSells/Trims$145.1M

Buys/Adds (2)

MW
Marshall Wace
Q2 2026 13F
$31.3M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%
FM
FMR LLC
Q1 2026 13F
$295.8M
added

Sells/Trims (1)

P7
Point72
Steven Cohen · Q1 2026 13F
$145.1M
sold
Signals like this: n=2234, 53% finished lower at D15, median -0.5% vs SPY -0.4%

1 more moves

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 1 moves

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 6, 2026

Earnings came in 22.2% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 6, 2026

Period ending

Jun 30, 2026

Earnings per share

-$2.87+22.22% beat

-$3.69 expected

Revenue

$0.00

Yahoo Finance

EPS and revenue: Yahoo Finance

Next report

Estimated report: Nov 4, 2026, in 4 days

Estimates as of Oct 31, 2026

EPS expected

-$3.63

-$5.60 to -$2.74

Last 30 days

12up4down

Analysts raising estimates

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 6, 2026	-$2.87est. -$3.69	+22.22%beat	$0.00Yahoo Finance	No year-ago quarter
Mar 31, 2026Reported May 7, 2026	-$3.20est. -$3.68	+13.01%beat	$0.00Yahoo Finance	No year-ago quarter
Dec 31, 2025Reported Feb 19, 2026	-$3.50est. -$3.13	-11.99%miss	$0.00Yahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 5, 2025	-$3.36est. -$3.49	+3.72%beat	$0.00SEC filing	-100.0%from $302.0K
Jun 30, 2025Reported Aug 4, 2025	-$3.31est. -$3.36	+1.49%beat	$0.00SEC filing	-100.0%from $357.0K
Mar 31, 2025Reported May 2, 2025	-$3.29est. -$3.21	-2.49%miss	$0.00SEC filing	-100.0%from $431.0K
Dec 31, 2024Reported Feb 28, 2025	-$2.94est. -$2.82	-4.29%miss	$8.6M · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 6, 2024	-$2.75est. -$1.95	-41.03%miss	$302.0KSEC filing	-35.5%from $468.0K

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $282.88
52-wk high: $392.70
High: $290.22
52-wk low: $154.45
Low: $282.88
Prev close: $285.48
Mkt cap: $8.06B
ROE: -38.9%
Beta: 2.81
P/S: 144.7x
P/B: 5.9x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $8.1B

Valuation

P/S144.69
P/B5.94

Quality

Operating margin0.0%
ROE-38.9%
ROA-25.7%

Growth

Beta2.81

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

63balanced

20D volatility

58%annualized

52-week range

$288.62

$154.45$392.70

20D support

$236.79recent floor

20D resistance

$299.12recent ceiling

Returns

5D +11.5%20D +0.6%60D -9.6%

Price vs moving averages

SMA20 +9.2%SMA50 -4.7%SMA200 -8.3%

Volume pace

1.19xvs prior 20D

Smart money at a glance

Filings to Oct 31, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: net buying of $2K to $30K in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: +$2K to +$30K netNet buying
Big fundsSEC 13F, quarter ended Jun 30, 2026: 1 added, 0 cutMore adding

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about PRAX filings

Are insiders buying or selling Praxis Precision Medicines Inc (PRAX) stock?

Neither. Praxis Precision Medicines Inc (PRAX) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded PRAX recently?

How current is this PRAX smart-money data?

13F: filed up to 45 days late.

Smart money on PRAX

Lean long2 sources:
- Politicians
- Funds
Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
- Jill DeSimone, sold $3.6M, scheduled plan sale, filed Jun 26
Lean short · thin1 sale · $3.6M
1 of 1 on scheduled plans. Form 4 filings.
Politicians
- Gilbert Cisneros, bought $1K–$15K, disclosed Oct 12
- Gilbert Cisneros, bought $1K–$15K, disclosed Sep 4
Lean long · thin2 buys · 0 salesCongress
Congress filings. Amounts are filing ranges, not prices, and filings can lag the trade.
Funds
Lean long2 added · 1 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about PRAX filings

Are insiders buying or selling Praxis Precision Medicines Inc (PRAX) stock?

Neither. Praxis Precision Medicines Inc (PRAX) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded PRAX recently?

How current is this PRAX smart-money data?

Funds

What funds are doing

4 moves · 6 mo

Buys/Adds$337.5MSells/Trims$145.1M

Buys/Adds (2)

MW
Marshall Wace
Q2 2026 13F
$31.3M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%
FM
FMR LLC
Q1 2026 13F
$295.8M
added

Sells/Trims (1)

P7
Point72
Steven Cohen · Q1 2026 13F
$145.1M
sold
Signals like this: n=2234, 53% finished lower at D15, median -0.5% vs SPY -0.4%

1 more moves

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 1 moves

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 6, 2026

Earnings came in 22.2% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 6, 2026

Period ending

Jun 30, 2026

Earnings per share

-$2.87+22.22% beat

-$3.69 expected

Revenue

$0.00

Yahoo Finance

EPS and revenue: Yahoo Finance

Next report

Estimated report: Nov 4, 2026, in 4 days

Estimates as of Oct 31, 2026

EPS expected

-$3.63

-$5.60 to -$2.74

Last 30 days

12up4down

Analysts raising estimates

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 6, 2026	-$2.87est. -$3.69	+22.22%beat	$0.00Yahoo Finance	No year-ago quarter
Mar 31, 2026Reported May 7, 2026	-$3.20est. -$3.68	+13.01%beat	$0.00Yahoo Finance	No year-ago quarter
Dec 31, 2025Reported Feb 19, 2026	-$3.50est. -$3.13	-11.99%miss	$0.00Yahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 5, 2025	-$3.36est. -$3.49	+3.72%beat	$0.00SEC filing	-100.0%from $302.0K
Jun 30, 2025Reported Aug 4, 2025	-$3.31est. -$3.36	+1.49%beat	$0.00SEC filing	-100.0%from $357.0K
Mar 31, 2025Reported May 2, 2025	-$3.29est. -$3.21	-2.49%miss	$0.00SEC filing	-100.0%from $431.0K
Dec 31, 2024Reported Feb 28, 2025	-$2.94est. -$2.82	-4.29%miss	$8.6M · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 6, 2024	-$2.75est. -$1.95	-41.03%miss	$302.0KSEC filing	-35.5%from $468.0K

Open: $282.88
52-wk high: $392.70
High: $290.22
52-wk low: $154.45
Low: $282.88
Prev close: $285.48
Mkt cap: $8.06B
ROE: -38.9%
Beta: 2.81
P/S: 144.7x
P/B: 5.9x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $8.1B

Valuation

P/S144.69
P/B5.94

Quality

Operating margin0.0%
ROE-38.9%
ROA-25.7%

Growth

Beta2.81

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

63balanced

20D volatility

58%annualized

52-week range

$288.62

$154.45$392.70

20D support

$236.79recent floor

20D resistance

$299.12recent ceiling

Returns

5D +11.5%20D +0.6%60D -9.6%

Price vs moving averages

SMA20 +9.2%SMA50 -4.7%SMA200 -8.3%

Volume pace

1.19xvs prior 20D

Praxis Precision Medicines Inc

Smart money at a glance

What do analysts expect?

Questions about PRAX filings

Smart money on PRAX

Questions about PRAX filings

What funds are doing

What insiders are doing

What Congress is doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 22.2% above what analysts expected.

Estimated report: Nov 4, 2026, in 4 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Praxis Precision Medicines Inc

Smart money at a glance

What do analysts expect?

Questions about PRAX filings

Smart money on PRAX

Questions about PRAX filings

What funds are doing

What insiders are doing

What Congress is doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 22.2% above what analysts expected.

Estimated report: Nov 4, 2026, in 4 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Praxis Precision Medicines Inc

Overview

Questions about PRAX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Praxis Precision Medicines Inc

Overview

Questions about PRAX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.